Blood News and Research

RSS

LRI announces 12 new research grants to drive innovation in lupus

The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.

9 Mar 2011

NHMRC awards $38.4M for cancer and blood cell research

Institute research into how cancer develops and blood cell production and function will today be awarded $38.4 million under the National Health and Medical Research Council's (NHMRC) program grants scheme.

9 Mar 2011

New nitric oxide producing topical products support healing process

GeNOsys, Inc. announced that it has developed a group of nitric oxide producing products for topical use. The products support blood flow and collagen growth to injured tissue and support the healing process.

9 Mar 2011

Belly laugh best for venous leg ulcers

Forget technology. The best prescription for patients with venous leg ulcers is good quality nursing care - and the occasional belly laugh!

9 Mar 2011

Chemotherapy drugs also kill malaria parasite

A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.

9 Mar 2011

Study: Roundworm protein can suppress inflammation in patients with sepsis

Research by the University of Liverpool has found that systemic inflammation caused by sepsis can be suppressed by a protein which occurs naturally in a type of roundworm.

8 Mar 2011

Treatment with sildenafil significantly reduces RP in patients with scleroderma

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis, also known as scleroderma.

8 Mar 2011

First hand transplant recipient on the way to recovery

A 26 year old mother has received the world’s first hand transplant. The 17 member surgical team from the Hand Transplant Program at Ronald Reagan UCLA Medical Center has performed the operation over 14 hours. They painstakingly attached tendons, blood vessels and nerves. The patient had lost her hand in a traffic accident 5 years ago. The patient is currently recovering.

8 Mar 2011

Diabetes belt mapped out in the US

A government commissioned team of researchers has now identified a diabetes belt in the U.S. County-by-county mapping shows that the highest rates of diabetes cut two paths - one strung through Tennessee, Kentucky and West Virginia, and another running eastward from Louisiana through Mississippi, Alabama, Georgia and South Carolina. This belt also touches parts of North Carolina, Virginia, Florida, Texas, Arkansas, Ohio and Pennsylvania. High-diabetes pockets crop up in Oklahoma, Michigan, Arizona, the Dakotas and elsewhere. The belt includes 644 counties in 15 states with the highest diabetes rates.

8 Mar 2011

$100 million in grants for medical research announced

More than $100 million in grants was announced this Tuesday for an ambitious research project that will try to find what makes cancer so hard to beat. This project received $21.3 million from the National Health and Medical Research Council grants.

8 Mar 2011

Conflicts in medical management of hemophilia

Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.

8 Mar 2011

New insight into malaria

A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.

8 Mar 2011

Nursing professors to develop new device for older adults

For those of us living the frenetic modern lifestyle, sitting in one place for a long period might seem like a vacation. But for those who are retired, it can lead to health complications.

8 Mar 2011

New discovery in childhood respiratory disease

Researchers have identified a critical part of the process by which one of the world's most common and dangerous early childhood infections, respiratory syncytial virus, causes disease.

8 Mar 2011

U-M receives Connections for Cardiovascular Health grant to expand 'Project Healthy Schools'

The AstraZeneca HealthCare Foundation program, Connections for Cardiovascular Health, today announced a grant of more than $252,000 to the University of Michigan Health System to expand "Project Healthy Schools."

8 Mar 2011

New method of detecting pre-atherosclerotic regions using MEMS thermal sensor

New method could sensitively detect pre-atherosclerotic regions that otherwise showed no clinical signs of atherosclerosis

8 Mar 2011

New advance in tissue engineering

Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center and colleagues reported today on a new advance in tissue engineering.

8 Mar 2011

New grant for expanding Project Healthy Schools to reduce childhood obesity

The AstraZeneca HealthCare Foundation program, Connections for Cardiovascular HealthSM, today announced a grant of more than $232,000 to the University of Michigan Health System to expand Project Healthy Schools.

8 Mar 2011

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the acquisition of all assets of Hema Metrics LLC related to its Crit-Line system.

8 Mar 2011